NCT07188441View on ClinicalTrials.gov

Treatment of Newly Diagnosed Central Malignant Germ Cell Tumor People With Teniposide Injection Combined With Cisplatin.

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 13, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
GCTGerm Cell TumorCentral Malignant Germ Cell Tumor
Interventions
DRUG

Teniposide Injection

teniposide 300mg/m2 for 5 days, cisplatin 75mg/m2 for 5 days

Trial Locations (1)

Unknown

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Chengcheng Guo

OTHER